Pages that link to "Q40511251"
Jump to navigation
Jump to search
The following pages link to Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease (Q40511251):
Displaying 50 items.
- alpha-Synuclein and neuronal cell death (Q21202835) (← links)
- Definition of a molecular pathway mediating α-synuclein neurotoxicity (Q26269832) (← links)
- Evaluation of Models of Parkinson's Disease (Q26772843) (← links)
- Mitochondrial biology and Parkinson's disease (Q26824090) (← links)
- Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors (Q27318127) (← links)
- The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease (Q28068464) (← links)
- The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease (Q28087330) (← links)
- Gene-environment interactions: key to unraveling the mystery of Parkinson's disease (Q28388674) (← links)
- Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy (Q28475940) (← links)
- Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation (Q28477043) (← links)
- Transient maintenance in bioreactor improves health of neuronal cells (Q28583636) (← links)
- Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system (Q30446265) (← links)
- Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions (Q30496792) (← links)
- Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra (Q33269934) (← links)
- Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates (Q33731243) (← links)
- Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein (Q33847712) (← links)
- Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein (Q34091623) (← links)
- Versatile somatic gene transfer for modeling neurodegenerative diseases (Q34285870) (← links)
- rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration (Q34465572) (← links)
- Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice (Q34492912) (← links)
- Advances in gene therapy for movement disorders. (Q34656049) (← links)
- Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease. (Q35101612) (← links)
- Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse (Q35675406) (← links)
- Genetics of Parkinson disease: paradigm shifts and future prospects. (Q36423921) (← links)
- Parkinson's disease: a rethink of rodent models. (Q36460467) (← links)
- Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines (Q36528609) (← links)
- Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites (Q36604979) (← links)
- Genetic causes of Parkinson's disease: extending the pathway. (Q36611513) (← links)
- Overexpression of alpha-synuclein following methamphetamine: is it good or bad? (Q36653961) (← links)
- Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization (Q36744478) (← links)
- High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction (Q36748956) (← links)
- Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease (Q36804685) (← links)
- Interactions between metals and alpha-synuclein--function or artefact? (Q36872892) (← links)
- Up-regulation of SNCA gene expression: implications to synucleinopathies (Q37004246) (← links)
- Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element (Q37166339) (← links)
- Direct detection of alpha synuclein oligomers in vivo (Q37180232) (← links)
- Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation (Q37184830) (← links)
- Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease (Q37190514) (← links)
- Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration (Q37241917) (← links)
- Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies (Q37388974) (← links)
- Advances in porcine genomics and proteomics--a toolbox for developing the pig as a model organism for molecular biomedical research (Q37759974) (← links)
- Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies (Q37778899) (← links)
- Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease (Q37796011) (← links)
- Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies (Q37851642) (← links)
- Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies (Q37857950) (← links)
- Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond (Q37880904) (← links)
- α-Synuclein and neuronal cell death (Q38039369) (← links)
- Protein phosphorylation in neurodegeneration: friend or foe? (Q38214594) (← links)
- Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role (Q38488082) (← links)
- Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? (Q38785080) (← links)